CR389, a Benzoimidazolyl Pyridinone Analog, Induces Cell Cycle Arrest and Apoptosis via p53 Activation in Human Ovarian Cancer PA-1 Cells

논문상세정보
' CR389, a Benzoimidazolyl Pyridinone Analog, Induces Cell Cycle Arrest and Apoptosis via p53 Activation in Human Ovarian Cancer PA-1 Cells' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • apoptotic induction
  • bax
  • cytochrome c
  • p21cip1
  • p53
  • pa-1 cells
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
211 0

0.0%

' CR389, a Benzoimidazolyl Pyridinone Analog, Induces Cell Cycle Arrest and Apoptosis via p53 Activation in Human Ovarian Cancer PA-1 Cells' 의 참고문헌

  • p53-dependent pathways of apoptosis
    Benchimol S. Cell Death Differ 8 : 1049 ~ 1051 [2001]
  • p 53-independent induction of p21 (WAF1/CIP1), reduction of cyclin b1 and G2/M arrest by the isoflavone genistein in human prostate carcinoma cells
    Choi YH Jpn. J. Cancer Res 91 : 164 ~ 173 [2000]
  • The role of serine/threonine phosphorylation in hematopoietic cytokine receptor signal transduction
    Mufson RA FASEB J 11 : 37 ~ 44 [1997]
  • Specificity of receptor tyrosine kinase signaling pathways: lessons from Drosophila
    Li W Genet. Eng. (NY) 19 : 167 ~ 182 [1997]
  • Role of p21(Waf-1) in regulating the G1 and G2/M checkpoints in ultraviolet-irradiated keratinocytes
    Maeda T J. Invest. Dermatol 119 : 513 ~ 521 [2002]
  • Inhibition of cell-cycle progression in HeLa cells by HY52, a novel cyclin-dependent kinase inhibitor isolated from Bauhinia forficata
    Lim H Cancer Lett 233 : 89 ~ 97 [2006]
  • Implications of apoptosis regulators in tumorigenesis
    Malaguarnera L. Cancer Metastasis Rev 23 : 367 ~ 387 [2004]
  • HY253, a novel decahydrofluorene analog, from Aralia continentalis, induces cell cycle arrest at the G(1) phase and cytochrome cmediated apoptosis in human lung cancer A549 cells
    Oh HL J. Ethnopharmacol 129 : 135 ~ 139 [2010]
  • HY253, a novel compound isolated from Aralia continentalis, induces apoptosis via cytochrome c-mediated intrinsic pathway in HeLa cells
    Oh HL Bioorg. Med. Chem. Lett 19 : 797 ~ 799 [2009]
  • HY251, a novel decahydrocyclopenta[a]indene analog, from Aralia continentalis induces apoptosis via downregulation of AR expression in human prostate cancer LNCaP cells
    Oh HL Bioorg. Med. Chem. Lett 21 : 1347 ~ 1349 [2011]
  • HY251, a novel cell cycle inhibitor isolated from Aralia continentalis, induces G 1 phase arrest via p53-dependent pathway in HeLa cells
    Oh HL Bioorg. Med. Chem. Lett 19 : 959 ~ 961 [2009]
  • G1 cell-cycle control and cancer
    Massague J Nature 432 : 298 ~ 306 [2004]
  • E2F and cell cycle control:a double-edged sword
    Stevens C Arch. Biochem. Biophys 412 : 157 ~ 169 [2003]
  • Death-associated protein kinase: from regulation of apoptosis to tumor suppressive functions and B cell malignancies
    Ng MH Apoptosis 7 : 261 ~ 270 [2002]
  • Cyclin-dependent kinases as a therapeutic target for stroke
    Osuga H Proc. Natl. Acad. Sci. USA 97 : 10254 ~ 10259 [2000]
  • Cyclin-dependent kinase pathways as targets for cancer treatment
    Shapiro GI J. Clin. Oncol 24 : 1770 ~ 1783 [2006]
  • Cooperative effects of genes controlling the G(2)/M checkpoint
    Chan TA Genes Dev 14 : 1584 ~ 1588 [2000]
  • Cell cycle arrest and cytochrome cmediated apoptotic induction by MCS-5A is associated with up-regulation of p16(INK4a) in HL-60 cells
    Choi BY Bioorg. Med. Chem. Lett 20 : 3880 ~ 3884 [2010]
  • Cell cycle arrest and apoptotic induction in LNCaP cells by MCS-C2, novel cyclin-dependent kinase inhibitor, through p53/p21WAF1/CIP1 pathway
    Park HY Cancer Sci 97 : 430 ~ 436 [2006]
  • Cell cycle a rrest a nd cytochrome c-mediated apoptotic induction in human lung cancer A549 cells by MSC-C2, an analogue of sangivamycin
    Kang J J. Microbiol. Biotechnol 20 : 433 ~ 437 [2010]
  • Benzyldihydroxyoctenone, a novel anticancer agent, induces apoptosis via mitochondrial-mediated pathway in androgen-sensitive LNCaP prostate cancer cells
    Moon HS Bioorg. Med. Chem. Lett 19 : 742 ~ 744 [2009]
  • ATP-site directed inhibitors of cyclin-dependent kinases
    Gray N Curr. Med. Chem 6 : 859 ~ 875 [1999]